A recent study from The Massachusetts Institute of Technology in Cambridge revealed just 18 percent of American studies on how to improve healthcare use the “random assignment” method, compared to 41 percent of studies outside the U.S.
“Randomized trials are critical because they enable researchers to isolate the effects of a treatment or program, such as a drug or a visit from a home health aide,” the article states. “They ensure that a change was due to the treatment or service and not some other factor.”
Some feel random assignment trials are time-consuming and expensive, MIT professor and an author of the study, Amy Finkelstein, PhD, told The Times. However, she said there are ways around this, and conversely, random assignment trials could save the industry billions in the long run.
More articles on leadership and management:
5 traits of uniquely charismatic leaders
Changing your leadership style in 4 steps
The best of Quint Studer: 10 must-read insights for healthcare leaders
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.